Boundless Bio Files 2025 Proxy Statement
Ticker: BOLD · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1782303
| Field | Detail |
|---|---|
| Company | Boundless Bio, INC. (BOLD) |
| Form Type | DEF 14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, corporate-governance, board-of-directors
TL;DR
Boundless Bio's proxy statement is out for 2025, detailing board and exec pay for FY24.
AI Summary
Boundless Bio, Inc. filed its definitive proxy statement on April 29, 2025, for its annual meeting. The filing details the company's board of directors, executive compensation, and other corporate governance matters for the fiscal year ending December 31, 2024. Key individuals like Christian Hassig, Klaus Wagner, Neil Abdollahian, Zachary Hornby, and Jami Rubin are listed as members of the board.
Why It Matters
This filing provides shareholders with crucial information regarding the company's leadership, compensation, and voting matters, enabling informed participation in corporate decisions.
Risk Assessment
Risk Level: low — This is a routine proxy filing providing information to shareholders and does not contain new material financial or operational information.
Key Numbers
- 2024-12-31 — Fiscal Year End (The proxy statement covers matters related to this fiscal year.)
- 20250429 — Filing Date (The date the definitive proxy statement was filed with the SEC.)
Key Players & Entities
- Boundless Bio, Inc. (company) — Registrant
- Christian Hassig (person) — Board Member
- Klaus Wagner (person) — Board Member
- Neil Abdollahian (person) — Board Member
- Zachary Hornby (person) — Board Member
- Jami Rubin (person) — Board Member
FAQ
What is the purpose of this DEF 14A filing?
This filing is a definitive proxy statement filed by Boundless Bio, Inc. pursuant to Section 14(a) of the Securities Exchange Act of 1934, providing information to shareholders for their annual meeting.
Who are the listed board members for the fiscal year ending December 31, 2024?
The listed board members include Christian Hassig, Klaus Wagner, Neil Abdollahian, Zachary Hornby, and Jami Rubin.
When was this proxy statement filed?
The definitive proxy statement was filed on April 29, 2025.
What is the company's primary business classification?
Boundless Bio, Inc. is classified under Pharmaceutical Preparations [2834].
What is the company's state of incorporation?
Boundless Bio, Inc. is incorporated in Delaware (DE).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 by Christian Hassig regarding Boundless Bio, Inc. (BOLD).